» Authors » W C-W Chu

W C-W Chu

Explore the profile of W C-W Chu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 135
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Lui G, Wong V, Wong G, Chu W, Wong C, Yung I, et al.
Aliment Pharmacol Ther . 2016 Jun; 44(4):411-21. PMID: 27301337
Background: Little is known about the importance of liver fibrosis and fatty liver in HIV-monoinfected individuals without hepatitis virus co-infection, particularly among the Asian population. Aim: To evaluate prevalence and...
2.
Wong V, Wong G, Chan H, Yeung D, Chan R, Chim A, et al.
Aliment Pharmacol Ther . 2015 Jul; 42(6):731-40. PMID: 26202818
Background: Patients with non-alcoholic steatohepatitis (NASH) have increased intestinal permeability and small intestine bacterial overgrowth. Aims: To test the hypothesis that endotoxemia is associated with non-alcoholic fatty liver disease (NAFLD)...
3.
4.
Shen J, Wong G, Chan H, Chan H, Yeung D, Chan R, et al.
Aliment Pharmacol Ther . 2014 Jan; 39(5):532-9. PMID: 24417250
Background: The rs738409 GG variant in patatin-like phospholipase 3 (PNPLA3) is associated with non-alcoholic fatty liver disease (NAFLD) and disease severity. However, it remains unclear if it contributes to the...
5.
Shen J, Chan H, Wong G, Chan A, Choi P, Chan H, et al.
Aliment Pharmacol Ther . 2012 Oct; 36(11-12):1057-66. PMID: 23066946
Background: The diagnosis of non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH) and fibrosis relies on liver biopsy. Non-invasive assessments are urgently needed. Aim: To evaluate cell apoptotic marker cytokeratin-18...